Lack of efficacy of a third tumour necrosis factor alpha antagonist after failure of a soluble receptor and a monoclonal antibody

Rheumatology
E Solau-GervaisR-M Flipo

Abstract

Some studies have highlighted the potential benefits of switching from infliximab to etanercept, or after failure of one or the other treatment. To our knowledge, no study has assessed the potential benefits of using the three anti-TNF-alpha agents that are currently available. The objective of this retrospective study was to assess the response to treatment in RA patients who had received the three anti-TNF-alpha agents, namely infliximab, etanercept and adalimumab. Among a cohort of 364 patients undergoing biological treatments since the year 2000, 284 had been treated with only one anti-TNF-alpha agent. Our assessment focused on the records of 70 patients who had received at least two anti-TNF-alpha agents. Twenty of the 70 patients had received all three anti-TNF-alpha agents (infliximab, etanercept and adalimumab). Effectiveness was assessed using the 28-joint Disease Activity Score (DAS28), and adverse events were reported for each anti-TNF-alpha treatment. Of the 70 patients who had received two anti-TNF-alpha agents, 32 had switched from an antibody to a soluble receptor; 45% of them had a good clinical response to the soluble receptor. Thirty patients had switched from a soluble receptor to an antibody; 45% of them had...Continue Reading

References

Jun 9, 2004·Joint, Bone, Spine : Revue Du Rhumatisme·Bernard Combe
Jul 2, 2004·Arthritis Research & Therapy·Sergio SchwartzmanG James Morgan
Nov 6, 2004·Arthritis and Rheumatism·E William St ClairUNKNOWN Active-Controlled Study of Patients Receiving Infliximab for the Treatment of Rheumatoid Arthritis of Early Onset Study Grou
Dec 14, 2004·Joint, Bone, Spine : Revue Du Rhumatisme·O BrocqL Euller Ziegler

❮ Previous
Next ❯

Citations

May 28, 2008·Rheumatology International·C DuftnerM Herold
May 23, 2008·Rheumatology·G MurphyM Molloy
Mar 2, 2010·Current Opinion in Rheumatology·Maya H Buch
Jun 20, 2007·Annals of the Rheumatic Diseases·Ronald F van Vollenhoven
Oct 13, 2006·The British Journal of Ophthalmology·Sabine BiesterManfred Zierhut
Jul 25, 2009·BMC Musculoskeletal Disorders·Federico Navarro-SarabiaJuan J Gómez-Reino
Feb 27, 2009·Clinical Drug Investigation·Bruno LaganàRaffaele D'Amelio
Nov 27, 2007·Joint, Bone, Spine : Revue Du Rhumatisme·Bruno FautrelUNKNOWN Société Française de Rhumatologie
Sep 28, 2014·Zeitschrift für Rheumatologie·F HeldmannJ Braun
Oct 5, 2007·Current Rheumatology Reports·Alan R Erickson, Ted R Mikuls
Jun 6, 2008·Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases·Antonella FioravantiMauro Galeazzi
Jan 31, 2015·Scandinavian Journal of Gastroenterology·Javier P Gisbert, María Chaparro
Oct 17, 2006·Expert Opinion on Investigational Drugs·Adriana H Tremoulet, Salvatore Albani
May 2, 2008·Expert Opinion on Investigational Drugs·Malini BajpaiAbhijit Ray
Mar 1, 2008·Expert Opinion on Drug Discovery·Marcus D Köller
Jun 16, 2010·Annals of Dermatology·Jae-Jeong Park, Seung-Chul Lee
Dec 6, 2011·Best Practice & Research. Clinical Rheumatology·Nishanthi Thalayasingam, John D Isaacs
Jan 26, 2011·Autoimmunity Reviews·Fabiola AtzeniRoberto Caporali
Oct 17, 2009·La Revue de médecine interne·P CarliJ-F Paris
Aug 22, 2009·Clinical Therapeutics·Martin Jan Bergman
Mar 21, 2007·Joint, Bone, Spine : Revue Du Rhumatisme·Thierry LequerréXavier le Loët
Jan 5, 2013·Scandinavian Journal of Rheumatology·K Chatzidionysiou, R F van Vollenhoven
Dec 28, 2012·The Korean Journal of Internal Medicine·Young Ok Jung, Hyun Ah Kim
Mar 26, 2013·Orvosi hetilap·Zoltán Szekanecz
Apr 18, 2017·Seminars in Arthritis and Rheumatism·Fabrizio CantiniDelia Goletti

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.